stella
beta
Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization — Stella
Recruiting
Back to Refractory Angina trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
Israel
Tel Aviv Sourasky Medical Center, Tel Aviv
Tel Aviv Medical Center, Tel Aviv
View full record on ClinicalTrials.gov